DiaMedica Therapeutics announced the appointment of Tanya Lewis to its board of directors; Lewis currently serves as chief development operations officer at Replimune Group.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 USD | -1.04% | -6.25% | +0.35% |
05-23 | DiaMedica Therapeutics Inc. Elects Rick Pauls as Director | CI |
05-09 | Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.35% | 109M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- DMAC Stock
- News DiaMedica Therapeutics Inc.
- DiaMedica Therapeutics Appoints Tanya Lewis to its Board of Directors